Latest Breaking News On - Interest activity symptoms - Page 1 : comparemela.com

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,

New yorkUnited statesMiami beachRoger mcintyreJeffrey cummingsHarryl smithAndrew muzykDarren oplandDavid gozalMark jacobsonDepartment of brain healthAxsome therapeutics incDrug administrationUniversity of torontoCorporate communicationsDevelopment program